First Time Loading...
S

Shanghai Junshi Biosciences Co Ltd
SSE:688180

Watchlist Manager
Shanghai Junshi Biosciences Co Ltd
SSE:688180
Watchlist
Price: 26.85 CNY -1.21% Market Closed
Updated: Jun 3, 2024

Shanghai Junshi Biosciences Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shanghai Junshi Biosciences Co Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai Junshi Biosciences Co Ltd
SSE:688180
Cash & Cash Equivalents
¥3.8B
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash & Cash Equivalents
¥15B
CAGR 3-Years
33%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash & Cash Equivalents
¥11.4B
CAGR 3-Years
108%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash & Cash Equivalents
¥3.8B
CAGR 3-Years
75%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash & Cash Equivalents
¥6.3B
CAGR 3-Years
68%
CAGR 5-Years
54%
CAGR 10-Years
20%
Imeik Technology Development Co Ltd
SZSE:300896
Cash & Cash Equivalents
¥3.1B
CAGR 3-Years
84%
CAGR 5-Years
71%
CAGR 10-Years
N/A

See Also

What is Shanghai Junshi Biosciences Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
3.8B CNY

Based on the financial report for Dec 31, 2023, Shanghai Junshi Biosciences Co Ltd's Cash & Cash Equivalents amounts to 3.8B CNY.

What is Shanghai Junshi Biosciences Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
6%

Over the last year, the Cash & Cash Equivalents growth was -37%. The average annual Cash & Cash Equivalents growth rates for Shanghai Junshi Biosciences Co Ltd have been 4% over the past three years , 6% over the past five years .